Pharmaceuticals

Revenue of the Therapeutic Proteins Market Predicted to Achieve $332.37 Billion by 2030, Driven by 13.5% CAGR

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the therapeutic proteins market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Therapeutic Proteins Market from 2026 to 2030?

The therapeutic proteins market has witnessed rapid expansion in recent years. It is anticipated to grow from $177.3 billion in 2025 to $200.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. The past growth of this market is attributable to the successful commercialization of insulin therapies, an increase in the prevalence of chronic diseases, the strong clinical efficacy demonstrated by protein drugs, the advancement of biotechnology research, and a rise in regulatory approvals.

The therapeutic proteins market size is set for rapid expansion in the coming years, with expectations to reach $332.37 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This growth during the forecast period is primarily driven by expanding oncology and immunology pipelines, an increase in biologics approvals, rising investment in biopharmaceutical research and development, the growing adoption of biosimilars, and improved manufacturing scalability.

Major trends anticipated in the forecast period include the expansion of recombinant protein therapies, an increasing demand for targeted biologics, the development and adoption of personalized protein medicines, a greater embrace of long-acting proteins, and significant advancements in protein expression systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2555&type=smp

What Drivers Are Affecting Demand In The Therapeutic Proteins Market?

The growing occurrence of long-term conditions, like diabetes, is projected to fuel expansion in the therapeutic protein market. Chronic diseases are defined as health issues persisting for at least a year, interfering with daily life, necessitating ongoing medical attention, or a combination of these factors. Diabetes is a persistent health condition where the body either produces insufficient insulin or fails to utilize insulin effectively. For managing diabetes and controlling blood sugar, various protein-based therapeutics, including insulin and GLP-1 receptor agonists, are employed. These treatments encourage insulin secretion when blood glucose levels are high and also diminish the production of glucagon, a different hormone that elevates blood sugar. For instance, in May 2024, the British Diabetic Association (Diabetes UK), a UK-based patient, healthcare professional and research charity, reported that approximately 4.4 million individuals in the UK were diagnosed with diabetes as of 2022-23. Among these cases, around 8% suffered from type 1 diabetes, with type 2 diabetes making up about 90%, and the remaining 2% comprising other, rarer forms of diabetes. Consequently, the rising incidence of chronic diseases, such as diabetes, is a key factor propelling the growth of the therapeutic protein market.

Which Segments Are Gaining Traction In The Therapeutic Proteins Market?

The therapeutic proteins market covered in this report is segmented –

1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone

2) By Function: Enzymatic And Regulatory Activity, Special Targeting Activity, Vaccines

3) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications

Subsegments:

1) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin

2) By Fusion Protein: Tnf-Alpha Inhibitors, Anti-Cd20 Fusion Proteins, Other Targeted Fusion Proteins

3) By Erythropoietin: Epoetin Alpha, Darbepoetin Alfa, Other Erythropoietin Variants

4) By Interferon: Interferon Alpha, Interferon Beta, Interferon Gamma

5) By Human Growth Hormone: Somatropin, Somatrem

6) By Follicle Stimulating Hormone: Follitropin Alpha, Follitropin Beta

What Trends Are Expected To Impact The Competitive Landscape Of The Therapeutic Proteins Market?

Leading companies in the therapeutic protein market are concentrating on introducing media systems to satisfy the increasing demand for therapeutic proteins and establish a competitive edge. The media system for therapeutic proteins functions as a production system specifically designed to optimize the manufacturing of therapeutic monoclonal antibodies. For example, in July 2023, Lonza Group AG, a pharmaceutical manufacturing company based in Switzerland, introduced the TheraPRO CHO (Chinese Hamster Ovary) Media System. This new cell culture platform is intended to improve productivity and quality in therapeutic protein manufacture. The two-part, chemically specified production technique is straightforward to use and simplifies media preparation. It offers full scalability and is backed by technical professionals with profound troubleshooting knowledge.

Who Are The Core Companies Influencing Trends In The Therapeutic Proteins Market?

Major companies operating in the therapeutic proteins market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring LLC, Chugai Pharmaceutical Co. Ltd., Biogen Inc., Kyowa Kirin Co. Ltd., Oramed Pharmaceuticals Inc., Sandoz International GmbH, Hualan Biological Engineering Inc., Genentech Inc., ProBiogen AG, Diasome Pharmaceuticals Inc., Generex Biotechnology Corp., GeneScience Pharmaceuticals Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Which Regions Are Projected To Dominate The Therapeutic Proteins Market In The Coming Years?

North America was the largest region in the therapeutic proteins market in 2025. The regions covered in the therapeutic proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Therapeutic Proteins Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2555&type=smp

Browse Through More Reports Similar to the Global Therapeutic Proteins Market 2026, By The Business Research Company

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Orthobiologics Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Proteomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795